Allen & Overy's Nicole Daley on the rebound in M&A activity in the pharma industry

Published Date
Mar 19, 2024
Related people
Nicole Daley, life sciences and M&A partner at Allen & Overy, discussed the steady pickup in M&A in the pharma industry after years of underperformance with PharmaVoice.

Nicole shared her thoughts on portfolio diversification and additive dealmaking, and how companies with a sharper focus can be more appealing to investors in the life sciences arena.

Read the full PharmaVoice article here.


First published on on the 19th March.

Content Disclaimer
This content was originally published by Allen & Overy before the A&O Shearman merger